Outcomes of pharmacist-managed diabetes care services in a community health center

David M. Scott, Steven T. Boyd, Michelle Stephan, Samuel C. Augustine, Thomas P. Reardon

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95% confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.

Original languageEnglish
Pages (from-to)2116-2122
Number of pages7
JournalAmerican Journal of Health-System Pharmacy
Volume63
Issue number21
DOIs
StatePublished - Nov 1 2006

Fingerprint

Community Health Centers
Managed Care Programs
Pharmacists
Blood Pressure
Type 2 Diabetes Mellitus
Control Groups
Quality of Life
Glycosylated Hemoglobin A
LDL Cholesterol
Health Status
Weight Loss
Body Mass Index
Nurses
Demography
Outcome Assessment (Health Care)
Confidence Intervals
Lipids

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Outcomes of pharmacist-managed diabetes care services in a community health center. / Scott, David M.; Boyd, Steven T.; Stephan, Michelle; Augustine, Samuel C.; Reardon, Thomas P.

In: American Journal of Health-System Pharmacy, Vol. 63, No. 21, 01.11.2006, p. 2116-2122.

Research output: Contribution to journalArticle

Scott, David M. ; Boyd, Steven T. ; Stephan, Michelle ; Augustine, Samuel C. ; Reardon, Thomas P. / Outcomes of pharmacist-managed diabetes care services in a community health center. In: American Journal of Health-System Pharmacy. 2006 ; Vol. 63, No. 21. pp. 2116-2122.
@article{0dc57cd2809d424ab5c6c3519cd9118a,
title = "Outcomes of pharmacist-managed diabetes care services in a community health center",
abstract = "Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95{\%} confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.",
author = "Scott, {David M.} and Boyd, {Steven T.} and Michelle Stephan and Augustine, {Samuel C.} and Reardon, {Thomas P.}",
year = "2006",
month = "11",
day = "1",
doi = "10.2146/ajhp060040",
language = "English",
volume = "63",
pages = "2116--2122",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "21",

}

TY - JOUR

T1 - Outcomes of pharmacist-managed diabetes care services in a community health center

AU - Scott, David M.

AU - Boyd, Steven T.

AU - Stephan, Michelle

AU - Augustine, Samuel C.

AU - Reardon, Thomas P.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95% confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.

AB - Purpose. The outcomes of pharmacist-managed diabetes care services in a community health center were studied. Methods. Eligible patients were over age 18 years and had a diagnosis of type 2 diabetes mellitus. Patients were randomly assigned by the clinical pharmacist and nurse to the intervention group (n = 76) or control group (n = 73). Patients in the intervention group were enrolled in a pharmacist-managed diabetes care program. Patients in the control group received the standard diabetes care. The primary endpoint was reduction in glycosylated hemoglobin (HbA1c); secondary outcome measures included weight loss, an improved body mass index, decreased blood pressure, and an improved lipid panel. Quality-of-life measures (health level, satisfaction, impact, worry about disease, and worry about social and vocational issues) were also assessed. Results. Demographic differences between groups were not remarkable. Mean HbA1c levels fell significantly (p <0.05) from baseline to nine months in both groups. A difference of 1.0 was reported between the groups' HbA1c levels (95% confidence interval, 0.08-1.78; p <0.05). Satisfaction level improved from 63.7 to 77.4 in the intervention group, which was significant when compared with the control group, whose satisfaction score improved from 57.0 to 63.4 (p <0.05). Conclusion. Patients with type 2 diabetes mellitus who received pharmacist-managed diabetes care demonstrated improved HbA1c, systolic blood pressure, and low-density-lipoprotein cholesterol levels and quality-of-life measures and met treatment goals more often than patients receiving standard care.

UR - http://www.scopus.com/inward/record.url?scp=33751040268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751040268&partnerID=8YFLogxK

U2 - 10.2146/ajhp060040

DO - 10.2146/ajhp060040

M3 - Article

VL - 63

SP - 2116

EP - 2122

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 21

ER -